Previous Section Index Home Page

24 Oct 2005 : Column 186W—continued

NHS Purchasing and Supply Agency

Mr. Oaten: To ask the Secretary of State for Health by how many the procurement staff establishment at the NHS Purchasing and Supply Agency is to be reduced; and what savings she estimates this will produce. [15376]

Jane Kennedy: The function and structure of the National Health Service Purchasing and Supply Agency (NHS PASA) has been subject to a review as part of the supply chain excellence programme (SCEP)—encompassing all Department of Health and NHS purchasing and supply activity. This review was undertaken by the commercial directorate and the output has been integrated into the arm's length body review process and ratified as part of the department wide programme.

The result is that the NHS PASA has refocused an increased level of resource on procurement and procurement support operations, while maintaining an establishment unchanged at 340.8 whole-time equivalent.

While no changes have been made to the establishment, the whole organisation has been subject to radical changes in structure, resource focus and work processes. The result is a significant increase in savings available to the NHS—including a target of £250 million per annum savings arising from the national contracting programme element of SCEP.


Mr. Davey: To ask the Secretary of State for Health how many primary school pupils in (a) England, (b) London and (c) Kingston and Surbiton are identified as (i) overweight and (ii) obese. [18399]

Caroline Flint: The available information, taken from the Health Survey for England, is shown in the table. No specific figures are available for Kingston and Surbiton, but these areas are included in the figure for London.
Prevalence of child overweight and obesity among English children aged five–10 by sex

Body mass index
(BMI) status
London Government office region
Overweight including obese30.530.8
Overweight including obese28.927.6
Number of children surveyed

UK National BMI percentile classification used to classify overweight and obesity in children.
Health Survey for England 2003

24 Oct 2005 : Column 187W

Oxygen Supply Service

Mr. Lansley: To ask the Secretary of State for Health when she expects the new regional oxygen supply service to be introduced; whether its start date has been delayed; and if she will make a statement. [18335]

Jane Kennedy: The new home oxygen service is to be introduced from 1 February 2006. Legal action prevented the Department from signing contracts to allow the service to be introduced from 1 October 2005 as intended. We consulted the national health service, pharmacist representatives and the new service contractors on the earliest possible date for introducing the new service. All agreed that it should be 1 February 2006 to avoid placing undue pressures on the home oxygen service when patient demand is at its peak in the months of December and January.

Peripheral Vascular Disease

Mr. Lansley: To ask the Secretary of State for Health how many finished admission episodes relating to peripheral vascular disease there have been in each year since 1997. [18358]

Mr. Byrne: The information requested is shown in the table.
Finished admission episodes—primary diagnosis—peripheral vascular disease (Please see selected codes in footnotes), national health service hospital trusts in England, 1997–98 to 2003–04

Finished admission episodes

1. A finished admission episode is the first period of in-patient care under one consultant within one health care provider. Please note that admissions do not represent the number of in-patients, as a person may have more than one admission within the year.
2. The primary diagnosis is the first of up to 14 (seven prior to 2002–03) diagnosis fields in the hospital episode statistics (HES) data set and provides the main reason why the patient was in hospital.
3. The following ICD-10 codes cover or include peripheral vascular disease. In some cases, they also include vascular diseases of other sites, but it is impossible to specify further:
170.2 Atherosclerosis of arteries or extremities
172.1 Aneurysm of artery of upper extremity 172.4 Aneurysm of artery of lower extremity
173.0 Raynaud's syndrome 173.1 Thromboangiitis obliterans [Buerger]
173.8 Other specified peripheral vascular diseases
173.9 Peripheral vascular disease, unspecified
174.2 Embolism and thrombosis of arteries of upper extremities
174.3 Embolism and thrombosis of arteries of lower extremities 174.4 Embolism and thrombosis of arteries of extremities, unspecified
177.0 Arteriovenous fistula, acquired
177.1 Stricture of artery
177.2 Rupture of artery
177.3 Arterial fibromuscular dysplasia
177.5 Necrosis of artery
177.6 Arteritis, unspecified
177.8 Other specified disorders of arteries and arterioles
177.9 Disorder of arteries and arterioles, unspecified
180.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities
180.1 Phlebitis and thrombophlebitis of femoral vein
180.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities
180.3 Phlebitis and thrombophlebitis of lower extremities, unspecified
180.8 Phlebitis and thrombophlebitis of other sites
180.9 Phlebitis and thrombophlebitis of unspecified site
183.0 Varicose veins of lower extremities with ulcer
183.1 Varicose veins of lower extremities with inflammation
183.2 Varicose veins of lower extremities with both ulcer and inflammation
183.9 Varicose veins of lower extremities without ulcer or inflammation
187.2 Venous insufficiency (chronic) (peripheral)
187.8 Other specified disorders of veins
187.9 Disorder of vein, unspecified 4. Figures are grossed for both coverage and missing/invalid clinical data, except for 2003–04, which are not yet adjusted for shortfalls.
HES, Health and Social Care Information Centre.

24 Oct 2005 : Column 188W


Miss McIntosh: To ask the Secretary of State for Health (1) if she will make a statement on the Government's policy on the future of (a) dispensing rural pharmacies and (b) community pharmacies; [17171]

(2) what assessment she has made of the financial viability of dispensing rural pharmacies. [17172]

Jane Kennedy: We are determined to improve access to, and the choice of, pharmacy services for patients. Community pharmacies provide a highly valued service and we are committed to their on-going development and integration in the national health service within the structure of the new contractual framework introduced from April 2005. We wish to encourage innovation and excellence in service provision while at the same time recognising the vital role community pharmacies play, particularly in poorer and rural areas.

We wish to ensure that patients are able to access the same standard of services in rural areas. Support has been available nationally through the essential small pharmacy scheme. This has, subject to certain conditions, provided a guaranteed minimum income to support a pharmacy which might otherwise be unviable.
24 Oct 2005 : Column 189W
From 1 April 2006, arrangements will change so that pharmacies within the scheme currently can either contract locally, again subject to conditions, with their NHS primary care trust for the provision of their services and continue to receive additional financial support or choose to be within the general provisions and payment system of the new contractual framework.

Public Health (Control of Disease) Act

Steve Webb: To ask the Secretary of State for Health what plans she has to review the Public Health (Control of Disease) Act 1984. [20028]

Caroline Flint [holding answer 20 October 2005]: Getting Ahead of the Curve", the infectious disease strategy published by the Chief Medical Officer in January 2002 made clear our intention of reviewing the Public Health (Control of Disease) Act 1984.

In preparation for the review, the Department has asked the Health Protection Agency (HPA) to consider how public health practitioners might make more effective use of the powers currently provided by the 1984 Act, and what difficulties practitioners find with the current powers and what changes might be desirable. We expect to receive the results of the first instalment of
24 Oct 2005 : Column 190W
the HPA's work shortly, and will want to consider with the HPA at that stage when and in what form it would be appropriate to publish the results of its work.

We will decide, in the light of work by the HPA and of other developments such as the World Health Organisation's adoption of new international health regulations, how to take the review forward. Our aim will be to consider whether and how the law could be modernised to ensure protection of the public while respecting the rights of the individual. If it seems that changes to the law would be desirable, we shall of course want to consult those affected before proceeding.

Next Section Index Home Page